The RMSCL has published a tender for "EMPANELMENT OF FIRMS FOR DRUGS AND MEDICINES" on the 09 May 2025. This tender belongs to Insulin category. This tender is published in Jaipur, Rajasthan location. The vendors interested in this tender and related Insulin tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
Related alert: pharmacy medicines Tenders | human insulin Tenders | allopathic medicine Tenders
Related categories: Acarbose Tenders | Glimepiride Tenders | Glipizide Tenders |
Around 22187 tenders were floated in Rajasthan in the past month with major spending on construction materials Tenders, school repairs Tenders, road construction Tenders
| Tender Title | EMPANELMENT OF FIRMS FOR DRUGS AND MEDICINES |
|---|---|
| Tender Description | dexamethasone inj ip 8mg/2ml [39] metronidazole tablets ip 400 mg (film coated) [123] surgical spirit ip (500 ml) [252] ors powder ip in orange/apple/ lemon flavour [274] biphasic isophane insulin inj ip (30 % soluble insulin and 70 % isophane insulin) inj. 40 iu/ml(r-dna origin) [279] tetanus vaccine (adsorbed) ip 5 ml vial [310] ascorbic acid tab ip 500 mg [387] ranitidine tab ip 300mg film coated [433] meropenem inj. ip 1gm [481] cefixime suspension ip 25mg/ml (paediatric drops) [511] dried factor viii fraction ip (iv use) 1000 iu/vial [689] recombinant f ix 500 iu with diluent [748] 3rd generation recombinant f viii 1000 iu with diluent [750] inj poractant alpha 80 mg/ml in pack of 1.5 ml [796] alectinib 150 mg cap. [nrd-9] adalimumab 40 mg inj. [nrd-147] cetuximab 100 mg inj. [nrd-190 ] denosumab 120 mg inj. [nrd-212] durvalumab 120 mg inj. [nrd-222] eribulin 0.5mg inj. [nrd-228] insulin aspart 100iu/ml injection 3 ml [nrd-258] rituximab 500 mg inj. [nrd-356] tenecte |
| Comments | dexamethasone inj ip 8mg/2ml [39] metronidazole tablets ip 400 mg (film coated) [123] surgical spirit ip (500 ml) [252] ors powder ip in orange/apple/ lemon flavour [274] biphasic isophane insulin inj ip (30 % soluble insulin and 70 % isophane insulin) inj. 40 iu/ml(r-dna origin) [279] tetanus vaccine (adsorbed) ip 5 ml vial [310] ascorbic acid tab ip 500 mg [387] ranitidine tab ip 300mg film coated [433] meropenem inj. ip 1gm [481] cefixime suspension ip 25mg/ml (paediatric drops) [511] dried factor viii fraction ip (iv use) 1000 iu/vial [689] recombinant f ix 500 iu with diluent [748] 3rd generation recombinant f viii 1000 iu with diluent [750] inj poractant alpha 80 mg/ml in pack of 1.5 ml [796] alectinib 150 mg cap. [nrd-9] adalimumab 40 mg inj. [nrd-147] cetuximab 100 mg inj. [nrd-190 ] denosumab 120 mg inj. [nrd-212] durvalumab 120 mg inj. [nrd-222] eribulin 0.5mg inj. [nrd-228] insulin aspart 100iu/ml injection 3 ml [nrd-258] rituximab 500 mg inj. [nrd-356] tenecte |
| Published Date | |
|---|---|
| Due Date | 08 Jun 2025 00:00:00 |
| Estimated Value | 363.02 Crore |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |